Tenon Medical Amends 8-K on Shareholder Vote Details
Ticker: TNONW · Form: 8-K/A · Filed: Jan 31, 2024 · CIK: 1560293
| Field | Detail |
|---|---|
| Company | Tenon Medical, Inc. (TNONW) |
| Form Type | 8-K/A |
| Filed Date | Jan 31, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: amendment, corporate-governance, shareholder-vote
TL;DR
**Tenon Medical just updated its shareholder vote details, clarifying prior reports.**
AI Summary
Tenon Medical, Inc. filed an 8-K/A Amendment No. 2 on January 31, 2024, to update its previous 8-K filing from December 21, 2023. This amendment clarifies information related to matters submitted to a vote of security holders, specifically concerning its Common Stock with a par value of $0.001 per share and Warrants. This matters to investors because it provides updated, accurate information regarding corporate governance and potential changes affecting their ownership stakes, ensuring transparency in shareholder voting outcomes.
Why It Matters
This filing provides updated information on shareholder voting matters, which is crucial for investors to understand the company's corporate governance and any potential changes to its capital structure.
Risk Assessment
Risk Level: low — This is an amendment to a previous filing, primarily for clarification, and does not introduce new significant risks.
Analyst Insight
A smart investor would review the original 8-K and its amendments to fully understand the outcomes of the shareholder vote and assess any implications for their investment in Tenon Medical, Inc.
Key Numbers
- $0.001 — Common Stock Par Value (The par value per share of Tenon Medical's Common Stock.)
Key Players & Entities
- Tenon Medical, Inc. (company) — the registrant filing the 8-K/A
- $0.001 (dollar_amount) — par value per share of Common Stock
- December 21, 2023 (date) — date of the earliest event reported in the original 8-K
- January 31, 2024 (date) — date the 8-K/A was filed
- TNON (company) — trading symbol for Tenon Medical, Inc. Common Stock
FAQ
What is the purpose of this 8-K/A filing by Tenon Medical, Inc.?
This 8-K/A is an Amendment No. 2 to a previous Form 8-K, filed to provide updated information regarding matters submitted to a vote of security holders, with the earliest event reported on December 21, 2023.
What specific securities are mentioned in relation to the shareholder vote?
The filing specifically mentions 'Common Stock, par value $0.001 per share' and 'Warrants' as the securities related to the shareholder vote.
What is the trading symbol for Tenon Medical, Inc.'s Common Stock?
The trading symbol for Tenon Medical, Inc.'s Common Stock is TNON.
When was the original event reported that this 8-K/A is amending?
The earliest event reported in the original filing, which this 8-K/A amends, occurred on December 21, 2023.
What is the par value of Tenon Medical, Inc.'s Common Stock?
The par value of Tenon Medical, Inc.'s Common Stock is $0.001 per share.
Filing Stats: 803 words · 3 min read · ~3 pages · Grade level 10.8 · Accepted 2024-01-31 16:27:31
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share TNON The Nasdaq Stock Mar
Filing Documents
- ea192560-8ka2_tenonmed.htm (8-K/A) — 32KB
- 0001213900-24-008465.txt ( ) — 247KB
- tnon-20231221.xsd (EX-101.SCH) — 4KB
- tnon-20231221_def.xml (EX-101.DEF) — 26KB
- tnon-20231221_lab.xml (EX-101.LAB) — 36KB
- tnon-20231221_pre.xml (EX-101.PRE) — 25KB
- ea192560-8ka2_tenonmed_htm.xml (XML) — 6KB
07 Submission of Matters to a Vote of
Item 5.07 Submission of Matters to a Vote of Security Holders. The Company convened its virtual Special Stockholders Meeting (the "Meeting") on January 30, 2024 at 1:30 p.m. Pacific Time that was a continuation of the adjourned special meeting of the Company's stockholders that was held on January 8, 2024, which was the continuation of the adjourned special meeting of the Company's stockholders that was held on December 21, 2023. A quorum was present for the Meeting. At the Meeting, Proposal 2 was submitted to the stockholders for approval as set forth in the definitive Proxy Statement as filed with the Securities and Exchange Commission on November 22, 2023. As of the record date, November 9, 2023, a total of 2,471,046 shares of common stock of the Company ("Common Stock") were issued and outstanding and entitled to vote. The Common Stock constitutes all of the securities of the Company entitled to vote at the Meeting. The holders of record of 1,777,436 shares of Common Stock were present in person or represented by proxy at said meeting. Such amounts represented approximately 71.93% of the Common Stock entitled to vote at such meeting. At the Meeting, the stockholders approved Proposal 2. The votes on Proposal 2 were cast as set forth below: Proposal No. 2 – To consider and vote on a proposal to approve an amendment to the Company's Second Amended and Restated Certificate of Incorporation, as amended (the "Certificate of Incorporation"), to expressly vest in the Board of Directors of the Company (the "Board") the authority to issue the preferred stock with powers, designations, preferences and relative, participating, optional or other rights, if any, or the qualifications, limitations or restrictions thereof as the Board; For Against Abstain 1,243,383 73,920 21,473 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 31, 2024 TENON MEDICAL, INC. By: /s/ Steven M. Foster Name: Steven M. Foster Title: Chief Executive Officer and President 3